Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Jim Miller

Outsourcing Outlook

http://www.pharmsource.com

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report, a monthly newsletter covering the contract drug development industry. A trial subscription can be obtained by calling 703.383.4903, by faxing 703.383.4905, by e-mailing info@pharmsource.com, or on the Web at www.pharmsource.com.

Articles
Health Systems Raise the Bar on Reimbursing New Drugs
July 2, 2014

As payers refuse to cover new drugs, CMOs take a hit.

Are CMOs Out of Synch With Market Realities?
May 30, 2014

Why can't the CMO industry break through to manufacture a greater share of drugs?

Stuck in Neutral
May 2, 2014

The CMO industry's value proposition is limiting its market penetration.

How Will CMO Ownership Changes Impact Market?
April 1, 2014

Changes in company ownership shake up the CMO industry.

Under New Ownership
March 2, 2014

Changes in company ownership shake up the CMO industry.

Evolving R&D Model Pressures Contract Services Market
January 31, 2014

The R&D model is in transition and creating new demands on contract services providers.

R&D in Transition
January 2, 2014

The R&D model is in transition and creating new demands on contract services providers.

Climate Change Drives New Opportunities in Outsourcing
January 2, 2014

Ongoing changes create new opportunities for CROs and CMOs.

Climate Change in Outsourcing
December 2, 2013

Ongoing changes create new opportunities for CROs and CMOs.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here